Malin Corporation plcMLC.IR
Price (close)
€7.00
Market cap
€30.3M
P/E
—
Revenue (FY)
€0
Net income
€0
Dividend yield
—
1-year total return
-14.6%
Net margin
—
Revenue growth
—
Debt / equity
—
What Malin Corporation plc does.
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| Net income | €37.8M | €12.9M | €0 | €0 |
| Free cash flow | -€6.2M | -€7.2M | -€3.2M | -€1.3M |
More on MLC.IR.
- Malin Corporation plc summary
- Malin Corporation plc financial statements
- Malin Corporation plc key metrics
- Malin Corporation plc health scores
- Malin Corporation plc valuation
- Malin Corporation plc dividends
- Malin Corporation plc peers
- Malin Corporation plc annual reports
Figures from Malin Corporation plc's annual reports (ESEF, via filings.xbrl.org) and Yahoo Finance, standardised automatically; prices are end-of-day closes. Not financial advice.